TABLE 1

Patient and Scan Characteristics of Patients Included in Repeatability Analysis (n = 10)

CharacteristicData
Age (y)74 (61–79)
Initial Gleason score8 (6–9)
PSA at PET/CT (ng/mL)9 (1–2,796)
Length (cm)178 (168–192)
Weight (kg)88 (68–94)
PCa stage
 Primary metastatic2 (20.0%)
 Biochemically recurrent3 (30.0%)
 Castration-resistant5 (50.0%)
Analyzed lesion type
 Bone21 (58.3%)
 Lymph node12 (33.3%)
 Intraprostatic3* (8.3%)
Androgen deprivation at PET/CT7 (70.0%)
Prior docetaxel3 (30.0%)
Injected activity (MBq)
 Test317 (280–331)
 Retest313 (254–341)
Uptake time (min)
 Test120 (118–153)
 Retest122 (111–149)
Test–retest difference†
 Injected activity (MBq)28 (8–63)
 Uptake time (min)3 (0–22)

  • ↵* Differences were not significant (P > 0.05).

  • ↵† 2 intraprostatic foci in 1 patient.

  • Qualitative data are numbers followed by percentages in parentheses; continuous data are median followed by range in parentheses.